Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Clinical trial NCT01735006 · COMPLETED

Trial details

NCT number: NCT01735006
Sponsor: Xiamen University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Cervical Cancer Vaginal Intraepithelial Neoplasia Vulvar Intraepithelial Neoplasia Persistent Infection

Start date: 2012-11-22
Primary completion: 2019-08-01
Enrollment: 7372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.